Tavaborole

Back to search

Molecule Structure

Scientific Name

Tavaborole

Description of the Drug

Tavaborole is an antifungal agent used to treat onychomycosis, a fungal infection of the nail.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09041

Brand Name(s)

Kerydin

Company Owner(s)

Cipla Ltd, Padagis Us Llc, Anacor Pharmaceuticals Inc, Aleor Dermaceuticals Ltd, Chartwell Rx Sciences Llc, Encube Ethicals Private Ltd, Amneal Pharmaceuticals Llc, Taro Pharmaceuticals Inc, Lupin Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Leucine-tRNA ligase SINGLE PROTEIN INHIBITOR CHEMBL3307222

Unichem Links

SureChEMBL SCHEMBL500016
DrugBank DB09041
PubChem: Thomson Pharma 16601086
PubChem 11499245
Nikkaji J2.495.581H
BindingDB 50370987
EPA CompTox Dashboard DTXSID00169888
DrugCentral 4877
Brenda 59010 78416
ChemicalBook CB42454906
rxnorm TAVABOROLE KERYDIN
PubChem: Drugs of the Future 22395917
ChEBI 77942
ZINC ZINC000169990691